Maharashtra FDA took strict action against ayurvedic drug manufacturer for violating DMR Act

The Maharashtra Food and Drugs Administration (FDA) recently raided Gynoveda Femtech Pvt. Ltd., an Ayurvedic drug manufacturer in Bhiwadi, Thane district, seizing drugs valued at ₹6,08,900.

Officials stated the seized products violated the Drugs and Magic Remedies (Objectionable Advertisement) (DMR) Act, 1954, due to misleading claims about their effectiveness. In addition to the seized products, the FDA halted the distribution of other Ayurvedic drugs from the same manufacturer, estimated at ₹3,62,60,900, because of improper labeling. These drugs will remain off the market until further notice from the Licensing Authority.

The operation involved a team of inspectors and senior FDA officials, reflecting the agency’s commitment to ensuring public health and regulatory compliance. Ongoing investigations will determine further legal actions against the manufacturer. Violators may face penalties, sanctions, and restrictions on future operations as mandated by the DMR Act, underscoring the importance of adherence to pharmaceutical regulations.